An overview of fotemustine in high-grade gliomas: from single agent to association with bevacizumab.

about

Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study.Trends in Malignant Glioma Monoclonal Antibody Therapy.

P2860

Q33432135-32AFF8A4-A82E-467D-A0EF-05458232FD67 Q54942652-0AD8C3D0-1956-4776-B5D3-F7C58FF11F2B

P2860

An overview of fotemustine in high-grade gliomas: from single agent to association with bevacizumab.

Item

http://www.wikidata.org/entity/Q38209678

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

An overview of fotemustine in ...... association with bevacizumab.

@en

type

Item

label

An overview of fotemustine in ...... association with bevacizumab.

@en

prefLabel

An overview of fotemustine in ...... association with bevacizumab.

@en

P1476

An overview of fotemustine in ...... o association with bevacizumab

@en

P2093

Alessandro Della Puppa

http://www.w3.org/2001/XMLSchema#string

Ardi Pambuku

http://www.w3.org/2001/XMLSchema#string

Luisa Bellu

http://www.w3.org/2001/XMLSchema#string

Patrizia Farina

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Malignant gliomas in adults

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature.

Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma

Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme.

Phase II study of fotemustine in recurrent supratentorial malignant gliomas.

Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience.

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.

P304

698542

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/698542

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Lombardi

Diego Cecchin

Vittorina Zagonel

P5008

ScienceSource

P577

2014-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262072401

http://www.w3.org/2001/XMLSchema#string

P698

24800248

http://www.w3.org/2001/XMLSchema#string

P921

glioma

brain cancer

organophosphorus compound

P932

3988896

http://www.w3.org/2001/XMLSchema#string

An overview of fotemustine in high-grade gliomas: from single agent to association with bevacizumab.

about

P2860

P2860

An overview of fotemustine in high-grade gliomas: from single agent to association with bevacizumab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P50

P5008

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P407

P478

P50

P5008

P577

P5875

P698

P921

P932